Lobbying

Merck Animal Health's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q1 2023; the issues it reports most are Agriculture and Animals.

Merck Animal Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Merck Animal Health lobbying by quarter
Merck Animal Health lobbying by quarter
QuarterAmountReports
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Agriculture$160K · 14 reports
  • Animals$160K · 14 reports
  • Maritime and fisheries$160K · 14 reports
  • Natural resources$160K · 14 reports
  • Budget and appropriations$60K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES14 reports
  • SENATE14 reports

Firms it paid

Firm
Forbes-Tate$700K14 quarters

Former officials lobbying for it

Former position
KRISTINA DUNKLINLegislative Director, Rep. Brooks, 2018 - 2019; Legislative Director, rep. Valadao, 2015-2018; Legislative Assistant, Rep. Valadao, 2014-2015Q3 2023

Lobbying reports

Filed by
07/20for Q2Forbes-Tate$50K
04/18for Q1Forbes-Tate$50K
01/18for Q4 2025Forbes-Tate$50K
25/10/18for Q3 2025Forbes-Tate$50K
25/07/16for Q2 2025Forbes-Tate$50K
25/04/15for Q1 2025Forbes-Tate$50K
25/01/17for Q4 2024Forbes-Tate$50K
24/10/17for Q3 2024Forbes-Tate$50K
24/07/12for Q2 2024Forbes-Tate$50K
24/04/13for Q1 2024Forbes-Tate$50K
24/01/16for Q4 2023Forbes-Tate$50K
23/10/17for Q3 2023Forbes-Tate$50K
23/07/15for Q2 2023Forbes-Tate$50K
23/04/17for Q1 2023Forbes-Tate$50K
23/03/08for Q1 2023Forbes-TateUnder $5,000